World’s First MAGE-A4-Targeting TCR-NK Therapy Zelluna Doses First Patient in Clinical Trial
Zelluna ASA, a Norwegian biotech company pioneering allogeneic cell therapies for solid cancers, recently announced that the first patient has…
When Synovial Sarcoma Mimics the Heart’s Most Common Tumor
A case report in AME Case Reports by Yun Xiao, Zhourui Liu, and Sha Li of the Department of Ultrasound…
Closing the AYA Gap: Clinical Trials, Genetic Testing, and Palliative Care for Young Sarcoma Patients
A new educational review in the American Society of Clinical Oncology Educational Book, authored by Sophie Jessop, MBBS, and colleagues,…
Then and Now: Decoding the Chromatin Machinery Behind Synovial Sarcoma
A new profile by Mariella Bodemeier Loayza Careaga, PhD, published in The Scientist, revisits biochemist Cigall Kadoch’s research nearly a…
Synovial Sarcoma Foundation Funds New Data Staff Scientist Position at CHOP
The Synovial Sarcoma Foundation is excited to announce that we have funded a new Data Staff Scientist position at Children’s…
TECELRA Receives Full FDA Approval, Expands Access to Adolescents with Synovial Sarcoma
US WorldMeds® announced that the U.S. Food and Drug Administration has granted full approval to TECELRA® (afamitresgene autoleucel), with an…
Synovial Sarcoma Foundation Announces Formation of Medical Advisory Board
11 Leading Oncologists and Researchers Unite to Accelerate Progress for Synovial Sarcoma Patients PHILADELPHIA [June 22, 2026] The Synovial Sarcoma…
Breaking Down Synovial Sarcoma’s Defenses: A study on Immune Evasion and Targeted Treatment
A landmark study from Jerby-Arnon, Neftel, Shore, and colleagues at the Broad Institute of Harvard and MIT, Massachusetts General Hospital,…
The Latest Synovial Sarcoma Data
A Global Survey for
Doctors Researchers Patients Advocates
Understanding the experiences of Synovial Sarcoma patients is essential to identifying challenges, improving treatment, and advancing research. Access comprehensive survey results by joining our Facebook Group, where you can connect with others in the community.
